Observational studyClinical and translational science2026
Prognostic Value of Systemic Inflammatory Markers in Predicting Peritoneal Metastasis in Gastric and Gastroesophageal Junction Cancer.
Observational study in Clinical and translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cancer and gastroesophageal junction cancer, primarily adenocarcinoma, originate in the stomach's mucosa. Peritoneal metastasis is a common pattern in gastric cancer. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), as systemic inflammation indicators, change before clinical symptoms, aiding early assessment of pathological changes. Without a single diagnostic method for detecting peritoneal metastasis in stomach and gastroesophageal junction cancer, this study examines the predictive value of NLR, PLR, and the albumin-to-derived neutrophil-to-lymphocyte ratio (Alb-dNLR) for peritoneal metastasis. A retrospective observational study was conducted at Kasturba Medical College and Kasturba Hospital, Manipal, in which NLR and PLR were calculated for 168 patients, while Alb-dNLR was determined for 155 patients due to unavailable variables required for calculation. The cutoff values established for albumin, dNLR, NLR, and PLR were 4.22, 2.577833, 1.832388, and 207.1929, respectively. Patients were categorized into high- and low-score groups using the Youden index, and these groups were subsequently compared for the occurrence of peritoneal metastasis. A statistically significant association was identified between the PLR (p-value: 0.004) and the NLR with peritoneal metastasis (p-value: 0.021). Conversely, no statistically significant association was observed between the Alb-dNLR score and peritoneal metastasis (p-value: 0.371). Patients exhibiting elevated preoperative NLR and PLR were at an increased risk of developing peritoneal metastasis. The study identified that elevated preoperative NLR and PLR serve as significant predictors of peritoneal metastasis in gastric cancer and gastroesophageal junction cancer. The study identified that elevated preoperative NLR and PLR were significantly associated with peritoneal metastasis in gastric cancer and gastroesophageal junction cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.